ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.340
-0.230 (-8.95%)
At close: Dec 5, 2025, 4:00 PM EST
2.440
+0.100 (4.27%)
After-hours: Dec 5, 2025, 7:23 PM EST
ProKidney Revenue
ProKidney had revenue of $217.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $744.00K. In the year 2024, ProKidney had annual revenue of $76.00K.
Revenue (ttm)
$744.00K
Revenue Growth
n/a
P/S Ratio
946.17
Revenue / Employee
$3,647
Employees
204
Market Cap
703.95M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PROK News
- 25 days ago - ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates - GlobeNewsWire
- 4 weeks ago - ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025 - GlobeNewsWire
- 5 weeks ago - ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025 - GlobeNewsWire
- 2 months ago - ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy - Seeking Alpha
- 3 months ago - ProKidney Corp. (PROK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 3 months ago - ProKidney Corp. (PROK) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
- 3 months ago - ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference - GlobeNewsWire